Breaking News Instant updates and real-time market news.

TSLA

Tesla

$349.75

-20.45 (-5.52%)

14:53
08/09/18
08/09
14:53
08/09/18
14:53

SEC stepping up probe of Tesla after Musk tweets, Bloomberg says

SEC enforcement attorneys were already gathering information about Tesla's public pronouncements on manufacturing goals and sales targets, but now attorneys in the San Francisco office are also examining whether CEO Elon Musk's recent tweet about having funding secured for a potential deal to have the company go private was meant to be factual, according to Bloomberg. The Wall Street Journal reported yesterday that the SEC was examining whether the statement made by Musk regarding taking the company private was truthful and has inquired why the disclosure was made on Twitter. Reference Link

  • 29

    Oct

TSLA Tesla
$349.75

-20.45 (-5.52%)

08/08/18
08/08/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. REACTIONS TO TESLA'S TALK OF GOING PRIVATE: Jefferies analyst Philippe Houchois raised his price target for Tesla (TSLA) to $360 from $250 after CEO Elon Musk suggested taking the company private. Going private "feels like the right thing to do," Houchois said. "Distraction or not, the move feels right even if Musk is downplaying how supportive public markets have been," the analyst adds. However, with Tesla unable to take on more debt, Houchois wondered who may fund the potential deal and end up as a new large shareholder. While Morgan Stanley analyst Adam Jonas sympathizes with Elon Musk's argument that Tesla could be better off as a private company, he questioned the feasibility of Musk actually being able to achieve that goal. Taking the company private would assume either that the company is on the verge of generating self-sustaining cash flows or that it can tap into a range of strategic sources of capital not previously at its disposal, said Jonas, who sees strategic value at Tesla but thinks the "LBO math required to support [a price of] $420 is extremely aggressive." MORGAN STANLEY SAYS SOUTHWEST A GOOD FIT FOR BERKSHIRE: Morgan Stanley analyst Kai Pan noted that Berkshire Hathaway (BRK.A) has shifted tone in recent years and become a top three shareholder of the "Big Four" U.S. airlines, including Southwest (LUV). Media reports from Forbes, CNN and others have discussed a possible acquisition by Berkshire of the airline, added Pan. He analyzed a theoretical acquisition and came to the conclusion that Southwest could be a strategic fit for Berkshire and the advantages could also be compelling for the airline. Pan estimates Berkshire could pay a 20-40% premium, or $70-80 per share for Southwest, in such a hypothetical takeover situation. Pan has an Overweight rating and $67 price target on Southwest shares. BARCLAYS POSITIVE ON SNAP GUIDANCE CHANGE: Barclays analyst Ross Sandler views Snap's (SNAP) Q2 results as a "mixed bag," with daily active users 2M below his estimate and revenue $20M above his estimate. More importantly, the change in approach towards guidance is "very welcomed and should help to reduce some of the volatility going forward," Sandler said. He believes this is a "big positive for long-term holders looking to get involved." The analyst kept an Overweight rating on Snap with a $16 price target. WAINWRIGHT SAYS INSMED LIKELY TO BE ACQUIRED: H.C. Wainwright analyst Andrew Fein raised his price target for Insmed (INSM) to $43 from $35 following the 12-2 FDA panel vote in favor of ALIS in refractory nontuberculous mycobacterial patients. Insmed is now likely to be acquired as ALIS "fits well within the pipeline of a number of larger companies," Fein said.
08/08/18
RBCM
08/08/18
NO CHANGE
Target $110
RBCM
Outperform
RBC Capital revisits idea of Celgene going private after Tesla proposal
Following yesterday's news that Tesla (TSLA) CEO Elon Musk would like to see his company go private, RBC analyst Brian Abrahams revisited his prior analysis of whether Celgene (CELG) should go private in order to better capture the medium-term value of future Revlimid cash flows not being appreciated by public markets and avoid volatility as it transitions to a post-Revlimid business model. Though acknowledging that the two companies are in completely different industries, he thinks the example of Musk shows that performing such a transaction on a large company "may not be completely unrealistic," Abrahams said. Such an LBO, or perhaps more likely an acquisition by a larger pharmaceutical company, could possibly help capture more value from Celgene's commercial and pipeline products, concludes Abrahams, who has an Outperform rating and $110 price target on Celgene shares.
08/08/18
BARD
08/08/18
NO CHANGE
Target $411
BARD
Outperform
Tesla $420 buyout price mentioned by Musk too low, says Baird
Baird analyst Ben Kallo believes the Tesla buyout price of $420 mentioned by Elon Musk is too low. He expects the shares to trade above that mark as investors will demand a higher premium, which will coincide with short covering. Kallo reiterated his Outperform rating and $411 price target on Tesla shares.
08/08/18
MSCO
08/08/18
NO CHANGE
Target $291
MSCO
Equal Weight
Musk may want to take Tesla private, but Morgan Stanley questions feasibility
While Morgan Stanley analyst Adam Jonas sympathizes with Elon Musk's argument that Tesla could be better off as a private company, he questions the feasibility of Musk actually being able to achieve that goal. Taking the company private would assume either that the company is on the verge of generating self-sustaining cash flows or that it can tap into a range of strategic sources of capital not previously at its disposal, said Jonas, who sees strategic value at Tesla but thinks the "LBO math required to support [a price of] $420 is extremely aggressive." The benefits of being private are outweighed by the risks of added financial leverage, which could be even more strategically limiting, added Jonas, who keeps an Equal Weight rating on Tesla shares with a price target of $291.

TODAY'S FREE FLY STORIES

STNL

Sentinel Energy

$9.81

(0.00%)

, STRK

Strike

$0.00

(0.00%)

07:35
10/19/18
10/19
07:35
10/19/18
07:35
Hot Stocks
Sentinel to buy Strike Capital majority stake, form publicly traded Strike Inc. »

Sentinel Energy Services,…

STNL

Sentinel Energy

$9.81

(0.00%)

STRK

Strike

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGX

Quest Diagnostics

07:35
10/19/18
10/19
07:35
10/19/18
07:35
Initiation
Quest Diagnostics initiated  »

Quest Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 23

    Oct

LH

LabCorp

07:35
10/19/18
10/19
07:35
10/19/18
07:35
Initiation
LabCorp initiated  »

LabCorp reinstated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

NFLX

Netflix

$346.71

-18.24 (-5.00%)

, PYPL

PayPal

$77.50

-2.61 (-3.26%)

07:35
10/19/18
10/19
07:35
10/19/18
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

NFLX

Netflix

$346.71

-18.24 (-5.00%)

PYPL

PayPal

$77.50

-2.61 (-3.26%)

CL

Colgate-Palmolive

$62.65

-0.48 (-0.76%)

ZION

Zions Bancorp

$47.33

-1.1 (-2.27%)

GRPN

Groupon

$3.51

-0.06 (-1.68%)

KEY

KeyCorp

$18.09

-0.66 (-3.52%)

ARRY

Array BioPharma

$15.46

0.4 (2.66%)

LKQ

LKQ Corp.

$27.98

-0.64 (-2.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 22

    Oct

  • 25

    Oct

  • 26

    Oct

  • 30

    Oct

  • 01

    Nov

  • 06

    Nov

  • 13

    Nov

  • 13

    Nov

  • 16

    Nov

  • 26

    Nov

  • 13

    Dec

AMRX

Amneal Pharmaceuticals

$18.51

0.02 (0.11%)

07:35
10/19/18
10/19
07:35
10/19/18
07:35
Hot Stocks
Amneal Pharma receives FDA approval for generic version of Isuprel Injection »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 28

    Feb

IPGP

IPG Photonics

07:35
10/19/18
10/19
07:35
10/19/18
07:35
Initiation
IPG Photonics initiated  »

IPG Photonics reinstated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

BNFT

Benefitfocus

$31.93

-1.42 (-4.26%)

07:34
10/19/18
10/19
07:34
10/19/18
07:34
Initiation
Benefitfocus initiated  »

Benefitfocus initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 13

    Nov

TRV

Travelers

$125.08

-1.39 (-1.10%)

07:34
10/19/18
10/19
07:34
10/19/18
07:34
Downgrade
Travelers rating change  »

Citi downgrades Travelers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OFG

OFG Bancorp

$15.20

-0.41 (-2.63%)

07:33
10/19/18
10/19
07:33
10/19/18
07:33
Earnings
OFG Bancorp reports Q3 EPS 42c, consensus 36c »

Reports Q3 CET1 capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 12

    Nov

  • 13

    Nov

ADNT

Adient

$29.73

-1.01 (-3.29%)

07:33
10/19/18
10/19
07:33
10/19/18
07:33
Earnings
Adient lowers FY18 revenue to $17.4B from $17.5B, consensus $17.44B »

Sees FY18 adjusted-EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

JCOM

j2 Global

$73.78

-1.64 (-2.17%)

07:33
10/19/18
10/19
07:33
10/19/18
07:33
Initiation
j2 Global initiated  »

j2 Global initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

URI

United Rentals

$118.09

-20.95 (-15.07%)

07:32
10/19/18
10/19
07:32
10/19/18
07:32
Recommendations
United Rentals analyst commentary  »

United Rentals price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAN

Manpower

$78.38

-1.09 (-1.37%)

07:32
10/19/18
10/19
07:32
10/19/18
07:32
Hot Stocks
Manpower CEO says Q3 results 'reflect a more challenging economic environment' »

Jonas Prising,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 28

    Oct

ERIC

Ericsson

$9.18

0.44 (5.03%)

07:32
10/19/18
10/19
07:32
10/19/18
07:32
Upgrade
Ericsson rating change  »

Ericsson upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAN

Manpower

$78.38

-1.09 (-1.37%)

07:31
10/19/18
10/19
07:31
10/19/18
07:31
Earnings
Manpower sees Q4 EPS $2.15-$2.23, consensus $2.50 »

"We are anticipating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 28

    Oct

VRNT

Verint

$45.76

-0.91 (-1.95%)

07:31
10/19/18
10/19
07:31
10/19/18
07:31
Initiation
Verint initiated  »

Verint initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAN

Manpower

$78.38

-1.09 (-1.37%)

07:30
10/19/18
10/19
07:30
10/19/18
07:30
Earnings
Manpower reports Q3 EPS $2.43, consensus $2.40 »

Reports Q3 revenue $5.4B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 28

    Oct

IPG

Interpublic Group

$22.48

0.28 (1.26%)

07:30
10/19/18
10/19
07:30
10/19/18
07:30
Initiation
Interpublic Group initiated  »

Interpublic Group resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

GE

General Electric

$12.38

0.19 (1.56%)

, SNAP

Snap

$6.81

-0.25 (-3.54%)

07:30
10/19/18
10/19
07:30
10/19/18
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

GE

General Electric

$12.38

0.19 (1.56%)

SNAP

Snap

$6.81

-0.25 (-3.54%)

HD

Home Depot

$180.43

-4.67 (-2.52%)

GME

GameStop

$15.06

-0.28 (-1.83%)

EOG

EOG Resources

$118.57

-1.56 (-1.30%)

VFC

VF Corp.

$87.07

-2.22 (-2.49%)

PTI

Proteostasis

$10.35

8.46 (447.62%)

GSVC

GSV Capital

$6.81

0.19 (2.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 25

    Oct

  • 30

    Oct

  • 02

    Nov

  • 07

    Nov

07:30
10/19/18
10/19
07:30
10/19/18
07:30
General news
Treasury Market Outlook: Treasury yields have reversed earlier gains »

Treasury Market Outlook:…

QLYS

Qualys

$73.99

-1.66 (-2.19%)

07:29
10/19/18
10/19
07:29
10/19/18
07:29
Initiation
Qualys initiated  »

Qualys initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:29
10/19/18
10/19
07:29
10/19/18
07:29
Hot Stocks
Breaking Hot Stocks news story  »

Sentinel Energy Services…

07:29
10/19/18
10/19
07:29
10/19/18
07:29
Hot Stocks
Breaking Hot Stocks news story  »

Sentinel Energy Services…

PYPL

PayPal

$77.50

-2.61 (-3.26%)

07:28
10/19/18
10/19
07:28
10/19/18
07:28
Recommendations
PayPal analyst commentary  »

PayPal results keep Baird…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

  • 13

    Nov

  • 26

    Nov

AEO

American Eagle

$20.94

-0.54 (-2.51%)

07:28
10/19/18
10/19
07:28
10/19/18
07:28
Upgrade
American Eagle rating change  »

Citi upgrades American…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.